A bill to amend the Pharmaceutical and Medical Devices (PMD) Law is expected to be submitted to the ordinary session of the Diet this year, which was convened on January 17 for a 150-day run. The proposed amendment is for…
BUSINESS
Mitsubishi Tanabe’s Oral Edaravone Accepted for FDA Review in ALS
Mitsubishi Tanabe Pharma said on January 13 that an oral suspension version of its ALS therapy Radicava (edaravone) has been accepted by the US FDA for review, with a target date set for May 12 under the priority review pathway.…
To read the full story
Related Article
- Mitsubishi Tanabe Eyes US Submission of Oral Edaravone by March-End
December 13, 2021
BUSINESS
- Jardiance’s New Indication Targets Around Half of Chronic Heart Failure Patients: Professor
January 28, 2022
- Yakult Honsha to Launch Velcade Generic in March
January 27, 2022
- Flatiron Health Joins Hands with National Cancer Center to Start Up Japan Biz
January 27, 2022
- Seikagaku Launches New Outpost in Canada
January 27, 2022
- Nippon Shinyaku Sets Up New Sales Firm in Tianjin to Expand Chinese Business
January 27, 2022
A total of 15 new drugs (APIs) joined the NHI price list in 2021 with peak sales forecasts topping at 10 billion yen, many of them in the area of orphan diseases and with few mega launches, according to a…
Japan’s all-important reimbursement policy panel on December 22 approved an outline of the next drug pricing reform scheduled for April 2022, which embraces plans to reward innovative new indications and introduce a grace period for so-called “spillover” re-pricing.The reform outline…
Remember what it was like back in March, when we all started working from home? There was a distinct change in the air - a sense of freedom and excitement about the novelty of being able to work from home.…
Biogen’s controversial Alzheimer’s drug aducanumab was filed for Japanese regulatory approval in December. If approved, it will be the first…
Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…